Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The PEARL Trial: A Randomized Trial of Amnioinfusion's Protective Effects on Respiratory and Longitudinal Pediatric Outcomes After Intrapartum Thick Meconium Exposure

NCT07274527 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.

NCT NCT07274527
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07274527 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The PEARL Trial: A Randomized Trial of Amnioinfusion's Protective Effects on Respiratory and Longitudinal Pediatric Outcomes After Intrapartum Thick Meconium Exposure
Lead sponsor
Medical College of Wisconsin
Phase
Not applicable
Overall status
Recruiting
Start date
May 15, 2026
Completion date
April 15, 2030
Enrollment
320 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amnioinfusion, cord blood, cpap, maternal morbidity, mechanical ventilation, meconium, neonatal acidosis, neonatal brain injury, neonatal respiratory distress related conditions, nicu admission, perinatal death, perinatal morbidity, surfactant